Emmecell
PrivateLast Round
Strategic
Jun 16, 2026
Total Funding Raised
$46M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Emmecell operates in Healthcare & Life Sciences and is based in Menlo Park, California. Its latest recorded funding round was a Strategic round in June 2026.
Emmecell is a biotechnology company that develops cell-based therapies for the treatment of eye diseases using its proprietary Magnetic Cell Delivery (MCD) nanoparticle platform.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Clinical Trials, Medical Devices
Business Model
B2B
Customer Profile
Services & Consulting, Revenue Share
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Emmecell Comparables
Compare Emmecell with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Trefoil Therapeutics | 81% | |
| ActualEyes, Inc. | 80% | |
| Cellusion Inc. | 80% |
For institutional investors. Book with your work email.
Emmecell Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Strategic | Jun 16, 2026 | ||||
| Series A | Jan 19, 2026 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 25, 2026
Monthly visitors grew 101% MoM, reaching 3.2K.
- Jan 23, 2026
Monthly visitors grew 71% MoM, reaching 2.2K.
For institutional investors. Book with your work email.
Emmecell Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Emmecell's valuation, stock price, and market status.
Is Emmecell a public or private company?
Emmecell is a private company.
What is the current stock price of Emmecell?
Emmecell is a private company, so its shares have no public market price. Caplight tracks Emmecell's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Emmecell worth (valuation)?
Valuation information for Emmecell is not publicly available.
Can I buy Emmecell stock?
Emmecell shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Emmecell's last funding round?
Emmecell's most recent funding round was Strategic on June 16, 2026.
Who are the main investors in Emmecell?
Investor information for Emmecell is not publicly disclosed.
Will Emmecell IPO soon?
No public IPO plans have been announced for Emmecell.
How can I track Emmecell secondary market activity?
Caplight tracks bids, offers, and trades in Emmecell's shares on secondary markets.